← Portfolio Scout

Portfolio company

Ad Scientiam

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

B2B SaaSDigital Health

About

This company develops smartphone-based medical software and digital biomarkers for patients and clinicians to monitor the progression of serious, disabling or rare diseases.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies